Mesothelial Cells: The Panacea for Ex Vivo Gene Therapy? The First Physiologically Regulated Transgene for Gene Therapy: Erythropoietin
- 1 November 1997
- journal article
- editorial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (16) , 1839-1841
- https://doi.org/10.1089/hum.1997.8.16-1839
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Progress in Transcriptionally Targeted and Regulatable Vectors for Genetic TherapyHuman Gene Therapy, 1997
- The TMC Worldwide Gene Therapy Enrollment Report, End 1996. Report of TMC Development, Paris, FranceHuman Gene Therapy, 1997
- Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic proteinProceedings of the National Academy of Sciences, 1996
- Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector.Proceedings of the National Academy of Sciences, 1996
- Myoblast transfer of human erythropoietin gene in a mouse model of renal failure.Journal of Clinical Investigation, 1995
- Erythropoietin Gene Transfer and Expression in Adult Normal Mice: Use of an Adenovirus VectorHuman Gene Therapy, 1994
- Systemic Delivery of Human Growth Hormone by Injection of Genetically Engineered MyoblastsScience, 1991